Skip to content

The assessment of the Plaque at RISK by non-invasive (molecular) imaging and modelling (ParisK): Validation of imaging techniques with histology

The assessment of the Plaque at RISK by non-invasive (molecular) imaging and modelling (ParisK): Validation of imaging techniques with histology - ParisK

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39382
Enrollment
71
Registered
2010-12-06
Start date
2011-08-23
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic plaque hardening of the arteries

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy - age 18 years or older (no maximum age) - informed consent by signing informed consent form regarding this study - inclusion criteria carotid endarterectomy: * symptomatic carotid artery stenosis 70-99% within 3 months of neurologic symptoms * symptomatic carotid artery stenosis 50-99% in man within 2 weeks of neurologic symptoms * asymptomatic carotid artery stenosis 70-99% with contralateral occlusion

Exclusion criteria

Exclusion criteria: * Severe co-morbidity, dementia or pregnancy * Standard contra-indications for MRI (ferromagnetic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.) * Patients who have a documented allergy to MRI or CT contrast media * Patients with a renal clearance

Design outcomes

Primary

MeasureTime frame
- MRI: correlation between neovascularisation in carotid atherosclerotic plaque characteristics assessed by dynamic 3.0 Tesla MRI and carotid atherosclerotic plaque at histology. - CT: correlation between size of lipid-rich-necrotic-core in dual-energy CT and histology.

Secondary

MeasureTime frame
- MRI: correlation between volume of LRNC, fibrous cap status, and volume of calcifications in carotid atherosclerotic plaques visualised by MRI and carotid atherosclerotic plaques at histology. - Ultrasound: correlation between deformation pattern and plaque composition and volume of LRNC at histology. - TCD: relation between number of recorded MES and fibrous cap status.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)